Radiofrequency (RF) continuous wave (CW) signals represent a promising tool to electropermeabilize cells, thanks to the possibility to use non-invasive applicators. A further improvement is represented by the use of CW signals to activate small lipid vesicles carrying a drug to the cell site, in order to enhance the drug acquisition by the cell. The ultimate challenge is the simultaneous electroporation of cells and vesicles induced by CW signals, obtaining a controlled drug delivery governed by electromagnetic fields. In this work, a 3D microdosimetric study is presented, together with an experimental setup, to plan in vitro drug delivery experiments, using non-thermal CW signals at 100 kHz, 10 MHz and 100 MHz, to simultaneously electroporate cells and liposome nanocarriers.
Controlled drug delivery mediated by CW electric fields. Experimental setup and 3D microdosimetry modelling / Caramazza, L., Paffi, A., Liberti, M., Apollonio, F.. - (2021), pp. 785-788. (51st European Microwave Conference, EuMC 2021 London; United Kingdom ) [10.23919/eumc50147.2022.9784177].
Controlled drug delivery mediated by CW electric fields. Experimental setup and 3D microdosimetry modelling
Caramazza, Laura;Paffi, Alessandra;Liberti, Micaela;Apollonio, Francesca
2021
Abstract
Radiofrequency (RF) continuous wave (CW) signals represent a promising tool to electropermeabilize cells, thanks to the possibility to use non-invasive applicators. A further improvement is represented by the use of CW signals to activate small lipid vesicles carrying a drug to the cell site, in order to enhance the drug acquisition by the cell. The ultimate challenge is the simultaneous electroporation of cells and vesicles induced by CW signals, obtaining a controlled drug delivery governed by electromagnetic fields. In this work, a 3D microdosimetric study is presented, together with an experimental setup, to plan in vitro drug delivery experiments, using non-thermal CW signals at 100 kHz, 10 MHz and 100 MHz, to simultaneously electroporate cells and liposome nanocarriers.| File | Dimensione | Formato | |
|---|---|---|---|
|
Caramazza_Controlled-drug-delivery_2021.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
400 kB
Formato
Adobe PDF
|
400 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


